Special Seminar: Prof Adrian Krainer, USA
From Base Pairs to Bedside: Antisense Therapeutics for Splicing Modulation
14 May 2019, 12:00
Tel Aviv University
You are invited to attend the Department of Human Molecular Genetics & Biochemistry special seminar, "From Base Pairs to Bedside: Antisense Therapuetics for Splicing Modulation" with Prof. Adrian Krainer, Cold Spring Harbor Laboratories, USA
Prof. Krainer is a recipient of an honorary award from Tel Aviv University for the invention of the first RNA-targeted antisense therapeutic Spinraza. This is the first drug approved to treat the neurodegenerative disease spinal muscular atrophy
Date: 14/5/19
Time: 12:00
Location: Lola Hall, Sackler School of Medicine
Host: Gil Ast